Table 1.
Patient Characteristics
| Characteristic | Total n = 92 |
|---|---|
| Median age at transplant in years | 33 (range 18-64) |
| Sex | |
| Male | 48 |
| Female | 44 |
| Initial remission duration | |
| Induction failure | 36 |
| ≤ 1 year | 34 |
| > 1 year | 22 |
| Prior RT history | |
| None | 46 |
| Single course of RT alone | 2 |
| Combined modality | 44 |
| No. prior chemotherapy regimens* | |
| One | 2 |
| Two | 74 |
| Three or more | 16 |
| Primary chemotherapy | |
| ABVD | 60 |
| Stanford V | 32 |
| Status at transplant | |
| Complete remission/minimal disease | 53 |
| Partial remission | 32 |
| Stable disease | 1 |
| Progressive disease | 6 |
| PET status at transplant** | |
| Positive | 29 |
| Minimal residual uptake (SUV2.0-3.5) | 6 |
| Negative | 42 |
| Not done | 15 |
| Risk factors | |
| Stage IV at relapse | 29 |
| B symptoms at relapse | 39 |
| >Minimal disease at transplant | 39 |
| No. of risk factors at transplant*** | |
| 0 | 24 |
| 1 | 37 |
| 2 | 23 |
| 3 | 8 |
Includes cytoreduction prior to transplant
Based on 77 patients who had PET-CT scans
Risk factors defined as stage IV at relapse, B symptoms at relapse, >minimal disease at transplant